NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $230,000 | +9.0% | 2,430 | 0.0% | 0.10% | -1.0% |
Q3 2019 | $211,000 | -35.5% | 2,430 | -32.1% | 0.10% | -38.1% |
Q2 2019 | $327,000 | -36.1% | 3,580 | -32.8% | 0.17% | -37.8% |
Q1 2019 | $512,000 | +1.8% | 5,324 | -9.1% | 0.27% | -13.7% |
Q4 2018 | $503,000 | -13.4% | 5,857 | -13.1% | 0.31% | -7.9% |
Q3 2018 | $581,000 | +14.1% | 6,738 | 0.0% | 0.34% | +24.5% |
Q2 2018 | $509,000 | -11.0% | 6,738 | -4.7% | 0.27% | -11.1% |
Q1 2018 | $572,000 | -9.4% | 7,073 | -6.0% | 0.31% | -4.7% |
Q4 2017 | $631,000 | -2.3% | 7,523 | 0.0% | 0.32% | -5.6% |
Q3 2017 | $646,000 | +2.9% | 7,523 | 0.0% | 0.34% | -0.9% |
Q2 2017 | $628,000 | +12.3% | 7,523 | 0.0% | 0.34% | -4.4% |
Q1 2017 | $559,000 | -99.9% | 7,523 | 0.0% | 0.36% | +16.5% |
Q4 2016 | $547,975,000 | +0.4% | 7,523 | +8.7% | 0.31% | 0.0% |
Q3 2016 | $545,947,000 | -5.2% | 6,923 | -0.6% | 0.31% | -6.1% |
Q2 2016 | $575,910,000 | +111727.2% | 6,963 | -3.5% | 0.33% | +9.3% |
Q1 2016 | $515,000 | – | 7,215 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |